| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2010-12-20 |
4 |
S |
$28.00 |
$140,000 |
D/D |
(5,000) |
31,000 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2014-10-01 |
4 |
A |
$28.54 |
$9,989 |
D/D |
350 |
1,084 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2016-10-01 |
4 |
A |
$28.92 |
$9,977 |
D/D |
345 |
3,951 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-03-31 |
4 |
D |
$29.03 |
$34,604 |
D/D |
(1,192) |
14,016 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-01-01 |
4 |
A |
$29.39 |
$9,993 |
D/D |
340 |
4,291 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-04-30 |
4 |
A |
$29.69 |
$21,228 |
D/D |
715 |
74,565 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-07-14 |
4 |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
36,455 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2015-04-01 |
4 |
A |
$30.43 |
$9,981 |
D/D |
328 |
1,724 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-10-03 |
4 |
AS |
$31.00 |
$77,507 |
D/D |
(2,500) |
36,455 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-04-01 |
4 |
A |
$31.29 |
$9,982 |
D/D |
319 |
5,837 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-04-01 |
4 |
A |
$31.49 |
$9,982 |
D/D |
317 |
4,608 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2012-04-25 |
4 |
AS |
$31.64 |
$316,432 |
D/D |
(10,000) |
10,416 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-05-17 |
4 |
AS |
$31.84 |
$33,145 |
D/D |
(1,041) |
18,334 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2015-01-01 |
4 |
A |
$31.97 |
$9,975 |
D/D |
312 |
1,396 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-08-10 |
4 |
S |
$32.00 |
$320,011 |
D/D |
(10,000) |
18,334 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-08-13 |
4 |
S |
$32.00 |
$480,478 |
D/D |
(15,000) |
18,334 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2012-06-19 |
4 |
D |
$32.00 |
$333,312 |
D/D |
(10,416) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-08-16 |
4 |
AS |
$32.04 |
$33,386 |
D/D |
(1,042) |
17,292 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-10-01 |
4 |
A |
$32.09 |
$9,980 |
D/D |
311 |
5,226 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-07-01 |
4 |
A |
$32.55 |
$9,993 |
D/D |
307 |
4,915 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2012-04-02 |
4 |
AS |
$34.08 |
$170,380 |
D/D |
(5,000) |
36,611 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-01-01 |
4 |
A |
$34.20 |
$9,986 |
D/D |
292 |
5,518 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2012-01-03 |
4 |
AS |
$34.75 |
$86,883 |
D/D |
(2,500) |
36,611 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2012-05-01 |
4 |
AS |
$34.99 |
$174,950 |
D/D |
(5,000) |
30,018 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2012-04-20 |
4 |
AS |
$35.00 |
$269,185 |
D/D |
(7,691) |
28,920 |
0 |
- |
|
294 Records found
|
|
Page 7 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
